150
Participants
Start Date
January 4, 2021
Primary Completion Date
May 1, 2024
Study Completion Date
November 19, 2024
Instylla HES
Instylla HES is a novel liquid embolic made of primarily water and polyethylene glycol (PEG)
TAE or cTACE
Bland TAE or cTACE
New York and Presbyterian Hospital (Cornell/Weill Medical College), New York
University of Pittsburgh, Pittsburgh
Charlotte Radiology, Charlotte
UAB Hospital, Birmingham
St. Elizabeth Healthcare, Edgewood
Central Arkansas Radiation Therapy Institute, Inc., Little Rock
Memorial Health Services, Long Beach
University of California, Irvine, Irvine
Olive View-UCLA Education & Research Institute, Sylmar
Boston Medical Center, Boston
Summit Health, Florham Park
University of Pennsylvania, Philadelphia
Sunnybrook Research Institute, Toronto
Mount Sinai, Toronto
Toronto General Hospital, Toronto
Lead Sponsor
Instylla, Inc.
INDUSTRY